WO2008115631A3 - Plant-produced compositions for treating papillomavirus infection and related methods - Google Patents
Plant-produced compositions for treating papillomavirus infection and related methods Download PDFInfo
- Publication number
- WO2008115631A3 WO2008115631A3 PCT/US2008/053498 US2008053498W WO2008115631A3 WO 2008115631 A3 WO2008115631 A3 WO 2008115631A3 US 2008053498 W US2008053498 W US 2008053498W WO 2008115631 A3 WO2008115631 A3 WO 2008115631A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- plant
- related methods
- papillomavirus infection
- produced compositions
- treating papillomavirus
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
- C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6068—Other bacterial proteins, e.g. OMP
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6075—Viral proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/64—Medicinal preparations containing antigens or antibodies characterised by the architecture of the carrier-antigen complex, e.g. repetition of carrier-antigen units
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/22—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a Strep-tag
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/20011—Papillomaviridae
- C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Abstract
Compositions for treating papillomavirus (PV) infection in a subject include a PV L2 polypeptide produced from a eukaryotic expression system.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US88887307P | 2007-02-08 | 2007-02-08 | |
US60/888,873 | 2007-02-08 | ||
US11/950,366 | 2007-12-04 | ||
US11/950,366 US20080213293A1 (en) | 2004-04-15 | 2007-12-04 | Prevention and Treatment of Recurrent Respiratory Papillomatosis |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2008115631A2 WO2008115631A2 (en) | 2008-09-25 |
WO2008115631A9 WO2008115631A9 (en) | 2008-11-20 |
WO2008115631A3 true WO2008115631A3 (en) | 2009-03-12 |
Family
ID=39766694
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2008/053498 WO2008115631A2 (en) | 2007-02-08 | 2008-02-08 | Plant-produced compositions for treating papillomavirus infection and related methods |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2008115631A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9717783B2 (en) | 2010-02-09 | 2017-08-01 | Stc.Unm | Immunogenic HPV L2-containing VLPs and related compositions, constructs, and therapeutic methods |
DK3368068T3 (en) | 2015-10-30 | 2021-02-22 | Univ Copenhagen | Virus-like particles with efficient epitope display |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6174532B1 (en) * | 1994-10-06 | 2001-01-16 | Cancer Research Campaign Technology Limited | L2 immunogenic peptides of papillomavirus |
US6599508B1 (en) * | 1994-10-07 | 2003-07-29 | Loyola University Of Chicago | Papilloma virus-like particles, fusion proteins as well as processes for their production |
US20050175632A1 (en) * | 2002-03-18 | 2005-08-11 | Wettendorff Martine A.C. | Viral antigens |
US20050249752A1 (en) * | 2002-10-17 | 2005-11-10 | Moon-Hee Sung | Vector for anti-hpv vaccine and transformed microorganism by the vector |
US20060029612A1 (en) * | 2004-04-15 | 2006-02-09 | Large Scale Biology Corporation | Prevention and treatment of recurrent respiratory papillomatosis |
-
2008
- 2008-02-08 WO PCT/US2008/053498 patent/WO2008115631A2/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6174532B1 (en) * | 1994-10-06 | 2001-01-16 | Cancer Research Campaign Technology Limited | L2 immunogenic peptides of papillomavirus |
US6599508B1 (en) * | 1994-10-07 | 2003-07-29 | Loyola University Of Chicago | Papilloma virus-like particles, fusion proteins as well as processes for their production |
US20050175632A1 (en) * | 2002-03-18 | 2005-08-11 | Wettendorff Martine A.C. | Viral antigens |
US20050249752A1 (en) * | 2002-10-17 | 2005-11-10 | Moon-Hee Sung | Vector for anti-hpv vaccine and transformed microorganism by the vector |
US20060029612A1 (en) * | 2004-04-15 | 2006-02-09 | Large Scale Biology Corporation | Prevention and treatment of recurrent respiratory papillomatosis |
Also Published As
Publication number | Publication date |
---|---|
WO2008115631A2 (en) | 2008-09-25 |
WO2008115631A9 (en) | 2008-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007121252A3 (en) | Tandem photovoltaic cells | |
EP2069586B8 (en) | Solar energy harvesting apparatus | |
EP3447979B8 (en) | Switching system and method based on virtual interfaces | |
WO2010009268A3 (en) | Methods of preparing photovoltaic modules | |
WO2011031489A3 (en) | Umbilical cord amniotic membrane products | |
WO2008091835A3 (en) | Implantable medical endoprostheses | |
WO2009005901A3 (en) | Virtual interactive presence systems and methods | |
EP2475879A4 (en) | Windmill conveyance system and method for using same | |
TW201129938A (en) | Personal mapping system | |
WO2009151591A3 (en) | Methods and compositions for generation of bax- and bak-deficient cell lines | |
EP2478427A4 (en) | Real time hand tracking, pose classification, and interface control | |
WO2007011742A3 (en) | Cigs photovoltaic cells | |
WO2011020115A3 (en) | Methods of treating cancer using growth factor retargeted endopeptidases | |
WO2007008861A3 (en) | Methods of transferring photovoltaic cells | |
AU2009271018A8 (en) | Tracking concentrator employing inverted off-axis optics and method | |
EP1978800A4 (en) | Milking system and method for vacuum regulation | |
EP2205771A4 (en) | Method, alloy and component | |
WO2012006204A3 (en) | Devices and methods for processing a biomaterial in a closed system | |
WO2011064668A3 (en) | Plants that reproduce via unreduced gametes | |
WO2008115631A3 (en) | Plant-produced compositions for treating papillomavirus infection and related methods | |
WO2011005496A3 (en) | Islet1 (isl1) and hearing loss | |
WO2008061148A3 (en) | Methods and compositions for cryopreserving oocytes | |
WO2011006097A3 (en) | Methods For Treating Toxicity | |
AU2007901043A0 (en) | Transaction processing system and method | |
AU2007900476A0 (en) | Transaction processing system and method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08799610 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08799610 Country of ref document: EP Kind code of ref document: A2 |